Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Breast Cancer Res Treat. 2020 Sep 11;185(1):195–204. doi: 10.1007/s10549-020-05922-w

Table 1.

Descriptive characteristics of BRCA noncarrier male breast cancer cases and controls

BRCA (−) male breast cancer cases Controls
(n=3647) (n=4269)
No. (%) No. (%) P*
Age at index cancer diagnosis, years
Median (interquartile range) 62 (53 – 69) 46 (40 – 53) <0.001
20–29 26 (0.7) 180 (4.2) <0.001
30–39 135 (3.7) 863 (20.2)
40–49 491 (13.5) 1746 (40.9)
50–59 931 (25.5) 829 (19.4)
60–69 1230 (33.7) 438 (10.3)
70–79 834 (22.9) 213 (5.0)
Ethnicity
White/European 2533 (69.5) 2848 (66.7) <0.001
Black 286 (7.8) 255 (6.0)
Asian 54 (1.5) 141 (3.3)
Latino 131 (3.6) 288 (6.7)
Native American 43 (1.2) 66 (1.5)
Near/Middle Eastern 34 (0.9) 38 (0.9)
Other 34 (0.9) 48 (1.1)
Multi-ethnic 532 (14.6) 585 (13.7)
Ashkenazi ancestry
No 3336 (91.5) 4142 (97.0) <0.001
Yes 311 (8.5) 127 (3.0)
Year of testing
2006 105 (2.9) 148 (3.5) 0.012
2007 433 (11.9) 427 (10.0)
2008 468 (12.8) 588 (13.8)
2009 517 (14.2) 686 (16.1)
2010 670 (18.4) 799 (18.7)
2011 701 (19.2) 791 (18.5)
2012 753 (20.6) 830 (19.4)
Any VUS
No 3584 (98.3) 4005 (93.8) <0.001
Yes 63 (1.7) 264 (6.2)
Personal history of non-breast/colon cancer
No 3240 (88.8) 3236 (75.8) <0.001
Yes 407 (11.2) 1033 (24.2)
*

Wilcoxon rank-sum test for comparison of medians and χ2 test for categorical variables